000			01913cam a2200265 4500500
005			20250112044551.0
041			_afre
042			_adc
100	1	0	_aMartin, Julie _eauthor
700	1	0	_a Jandot, Élise _eauthor
700	1	0	_a Bréant, Valentine _eauthor
700	1	0	_a Sellier-Leclerc _eauthor
700	1	0	_a Mouchoux, Christelle _eauthor
700	1	0	_a Lattard, Claire _eauthor
700	1	0	_a Bacchetta, Justine _eauthor
700	1	0	_a Larger, Magali _eauthor
700	1	0	_a Dode, Xavier _eauthor
700	1	0	_a Hoegy, Delphine _eauthor
245	0	0	_aIntegrating clinical pharmacy activities into the care pathway for pediatric kidney transplant patients
260			_c2023.
500			_a45
520			_aThe pediatric kidney transplant pathway is at risk of care discontinuation, despite therapeutic adherence being essential. The aim of this feasibility study is to evaluate the integration of clinical pharmacy activities into this care pathway. The study is divided into three stages: structuring, implementing, and evaluation. In the pre-transplant and immediate and remote post-transplant phases, interviews were conducted, alongside the pharmaceutical analysis of medication prescriptions. Across an 8-month period, 32 patients were included. All patients included in the pre-transplant and immediate post-transplant phases benefited from the activities. At M0, all the prescriptions analyzed resulted in at least one problem being detected. Half of the transplanted patients benefited from M1 maintenance, one patient from M3 maintenance, and no M6 follow-up could be carried out. This study shows that integrating clinical pharmacy activities into the care pathway is highly feasible.
786	0		_nNéphrologie & Thérapeutique | Volume 19 | 7 | 2023-07-01 | p. 568-574 | 1769-7255
856	4	1	_uhttps://shs.cairn.info/journal-nephrologie-therapeutique-2023-7-page-568?lang=en
999			_c191247 _d191247